Chaperoning erythropoiesis

Blood

Volumn 113, Issue 10, 2009, Pages 2136-2144

  Weiss, Mitchell J ^a   Santos, Camila O Dos ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; CHAPERONE; GLOBIN; HEAT SHOCK PROTEIN 70; HEMOGLOBIN; MITOCHONDRIAL PROTEIN;

CELL VIABILITY; ERYTHROBLAST; ERYTHROPOIESIS; GLOBIN SYNTHESIS; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

EID: 64049099283     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-115238     Document Type: Review

References (146)

1. Morimoto R, Fodor E. Cell-specific expression of heat shock proteins in chicken reticulocytes and lymphocytes. J Cell Biol. 1984;99:1316-1323.
2. Banerji SS, Laing K, Morimoto RI. Erythroid lineage-specific expression and inducibility of the major heat shock protein HSP70 during avian embryogenesis. Genes Dev. 1987;1:946-953.
3. Banerji SS, Theodorakis NG, Morimoto RI. Heat shock-induced translational control of HSP70 and globin synthesis in chicken reticulocytes. Mol Cell Biol. 1984;4:2437-2448.
4. Davis JQ, Dansereau D, Johnstone RM, Bennett V. Selective externalization of an ATP-binding protein structurally related to the clathrin-uncoating ATPase/heat shock protein in vesicles containing terminal transferrin receptors during reticulocyte maturation. J Biol Chem. 1986;261: 15368-15371.
5. Singh MK, Yu J. Accumulation of a heat shock like protein during differentiation of human eryhroid cell line K562. Nature. 1984;309:631-633.
6. Frydman J. Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem. 2001;70:603-647.
7. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 2002;295:1852-1858.
8. Liberek K, Lewandowska A, Zietkiewicz S. Chaperones in control of protein disaggregation. EMBO J. 2008;27:328-335.
9. Saibil HR. Chaperone machines in action. Curr Opin Struct Biol. 2008;18:35-42.
10. Young JC, Agashe VR, Siegers K, Hartl FU. Pathways of chaperone-mediated protein folding in the cytosol. Nat RevMol Cell Biol. 2004;5:781-791.
11. Albanese V, Yam AY, Baughman J, Parnot C, Frydman J. Systems analyses reveal two chaperone networks with distinct functions in eukaryotic cells. Cell. 2006;124:75-88.
12. Shorter J. Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals. 2008;16:63-74.
13. Ballinger CA, Connell P, Wu Y, et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol. 1999;19:4535-4545.
14. Imai Y, Soda M, Hatakeyama S, et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell. 2002;10:55-67.
15. Murata S, Minami Y, Minami M, ChibaT, Tanaka K. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2001; 2:1133-1138.
16. Westhoff B, Chapple JP, van der Spuy J, Hohfeld J, Cheetham ME. HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome. Curr Biol. 2005;15:1058-1064.
17. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell. 2006;125:443-451.
18. Wickner S, Maurizi MR, Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science. 1999;286:1888-1893.
19. Horwich A. Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions. J Clin Invest. 2002;110:1221-1232.
20. Vicart P, Caron A, Guicheney P, et al. Amissense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998;20:92-95.
21. Clark JI, Muchowski PJ. Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol. 2000;10:52-59.
22. Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci. 2005;6:11-22.
23. Nathan DG, Gunn RB. Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am J Med. 1966;41:815-830.
24. Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol. 2002;9:123-126.
25. Grad I, Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol. 2007;275:2-12.
26. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006;31:164-172.
27. Chen Y, Voegeli TS, Liu PP, Noble EG, Currie RW. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm Allergy Drug Targets. 2007;6:91-100.
28. Mayer MP. Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies. Rev Physiol Biochem Pharmacol. 2005;153:1-46.
29. Brodsky JL, Chiosis G. Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators. Curr Top Med Chem. 2006;6:1215-1225.
30. Pearl LH, Prodromou C, Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J. 2008;410:439-453.
31. Nyalwidhe J, Lingelbach K. Proteases and chaperones are the most abundant proteins in the parasitophorous vacuole of Plasmodium falciparum-infected erythrocytes. Proteomics. 2006;6: 1563-1573.
32. Botha M, Pesce ER, Blatch GL. The Hsp40 proteins of Plasmodium falciparum and other apicomplexa: regulating chaperone power in the parasite and the host. Int J Biochem Cell Biol. 2007;39:1781-1803.
33. Acharya P, Kumar R,Tatu U. Chaperoning acellular upheaval in malaria: heat shock proteins in Plasmodium falciparum. Mol Biochem Parasitol. 2007;153:85-94.
34. Pavithra SR, Banumathy G, Joy O, Singh V, Tatu U. Recurrent fever promotes Plasmodium falciparum development in human erythrocytes. J Biol Chem. 2004;279:46692-46699.
35. Kumar R, Musiyenko A, Barik S. The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin. Malar J. 2003;2:30.
36. Banumathy G, Singh V, Pavithra SR, Tatu U. Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes. J Biol Chem. 2003;278:18336-18345.
37. Ellis SR, Lipton JM. Diamond Blackfan anemia: a disorder of red blood cell development. Curr Top Dev Biol. 2008;82:217-241.
38. Lui JC, Kong SK. Heat shock protein 70 inhibits the nuclear import of apoptosis-inducing factor to avoid DNA fragmentation in TF-1 cells during erythropoiesis. FEBS Lett. 2007;581:109-117.
39. Carlile GW, Smith DH, Wiedmann M. Caspase-3 has a nonapoptotic function in erythroid maturation. Blood. 2004;103:4310-4316.
40. Zermati Y, Garrido C, Amsellem S, et al. Caspase activation is required for terminal erythroid differentiation. J Exp Med. 2001;193:247-254.
41. Kolbus A, Pilat S, Husak Z, et al. Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J Exp Med. 2002;196:1347-1353.
42. De Maria R, Testa U, Luchetti L, et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 1999;93:796-803.
43. De Maria R, Zeuner A, Eramo A, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 [see comments]. Nature. 1999;401:489-493.
44. Koury MJ, Bondurant MC. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J Cell Physiol. 1988;137: 65-74.
45. Ribeil JA, Zermati Y, Vandekerckhove J, et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature. 2007;445:102-105.
46. Cande C, Cohen I, Daugas E, et al. Apoptosis inducing factor (AIF): a novel caspase-indepen-dent death effector released from mitochondria. Biochimie. 2002;84:215-222.
47. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene. 2004;23:2861-2874.
48. Gurbuxani S, Schmitt E, Cande C, et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene. 2003;22:6669-6678.
49. Matsumori Y, Hong SM, Aoyama K, et al. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J Cereb Blood Flow Metab. 2005;25:899-910.
50. Ravagnan L, Gurbuxani S, Susin SA, et al. Heat shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001;3:839-843.
51. Craven SE, French D, Ye W, de Sauvage F, Rosenthal A. Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome. Blood. 2005;105:3528-3534.
52. Voisine C, Craig EA, Zufall N, von Ahsen O, Pfanner N, Voos W. The protein import motor of mitochondria: unfolding and trapping of preproteins are distinct and separable functions of matrix Hsp70. Cell. 1999;97:565-574.
53. Craig EA, Kramer J, Shilling J, et al. SSC1, an essential member of the yeast HSP70 multigene family, encodes a mitochondrial protein. Mol Cell Biol. 1989;9:3000-3008.
54. Yokoyama K, Fukumoto K, Murakami T, et al. Extended longevity of Caenorhabditis elegans by knocking in extra copies of hsp70F, a homolog of mot-2 (mortalin)/mthsp70/Grp75. FEBS Lett. 2002;516:53-57.
55. Kaul SC, Yaguchi T, Taira K, Reddel RR, Wadhwa R. Overexpressed mortalin (mot-2)/mthsp70/ GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts. Exp Cell Res. 2003;286:96-101.
56. Ohtsuka R, Abe Y, Fujii T, et al. Mortalin is a novel mediator of erythropoietin signaling. Eur J Haematol. 2007;79:114-125.
57. Rutherford SL, Zuker CS. Protein folding and the regulation of signaling pathways. Cell. 1994;79: 1129-1132.
58. Pearl LH. Hsp90 and Cdc37: a chaperone cancer conspiracy. Curr Opin Genet Dev. 2005;15:55-61.
59. Higgs DR, Wood WG. Long-range regulation of alpha globin gene expression during erythropoiesis. CurrOpin Hematol. 2008;15:176-183.
60. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol. 2005;33:259-271.
61. Graves PE, Henderson DP, Horstman MJ, Solomon BJ, Olson JS. Enhancing stability and expression of recombinant human hemoglobin in E. coli: progress in the development of a recombinant HBOC source. Biochim Biophys Acta. 2008; 1784:1471-1479.
62. Yip YK, Waks M, Beychok S. Influence of prosthetic groups on protein folding and subunit assembly, I: conformational differences between separated human alpha-and beta-globins. J Biol Chem. 1972;247:7237-7244.
63. Vasudevan G, McDonald MJ. Ordered heme binding ensures the assembly of fully functional hemoglobin: a hypothesis. Curr Protein Pept Sci. 2002;3:461-466.
64. Ascoli F, Fanelli MR, Antonini E. Preparation and properties of apohemoglobin and reconstituted hemoglobins. Methods Enzymol. 1981;76:72-87.
65. Oton J, Franchi D, Steiner RF, Martinez CF, Bucci E. Fluorescence studies of internal rotation in apohemoglobin alpha-chains. Arch Biochem Biophys. 1984;228:519-524.
66. O'Malley SM, McDonald MJ. Monitoring the effect of subunit assembly on the structural flexibility of human alpha apohemoglobin by steady-state fluorescence. J Protein Chem. 1994;13:561-567.
67. Waks M, Yip YK, Beychok S. Influence of prosthetic groups on protein folding and subunit assembly: recombination of separated human alpha-and beta-globin chains with heme and alloplex interactions of globin chains with heme containing subunits. J Biol Chem. 1973;248: 6462-6470.
68. Hargrove MS, Olson JS. The stability of holomyoglobin is determined by heme affinity. Biochemistry. 1996;35:11310-11318.
69. Komar AA, Kommer A, Krasheninnikov IA, Spirin AS. Cotranslational folding of globin. J Biol Chem. 1997;272:10646-10651.
70. Komar AA, Kommer A, Krasheninnikov IA, Spirin AS. Cotranslational heme binding to nascent globin chains. FEBS Lett. 1993;326:261-263.
71. Tahara T, Sun J, Nakanishi K, et al. Heme positively regulates the expression of b-globin at the locus control region via the transcriptional factor Bach1 in erythroid cells. J Biol Chem. 2004;279: 5480-5487.
72. Tahara T, Sun J, Igarashi K, Taketani S. Heme dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells. Biochem Biophys Res Commun. 2004;324:77-85.
73. Sun J, Brand M, Zenke Y, Tashiro S, Groudine M, Igarashi K. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci USA. 2004;101:1461-1466.
74. Chen JJ. Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood. 2007;109:2693-2699.
75. Han AP, Yu C, Lu L, et al. Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J. 2001;20:6909-6918.
76. Han AP, Fleming MD, Chen JJ. Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyriaand beta-thalassemia. J Clin Invest. 2005; 115:1562-1570.
77. Liu S, Bhattacharya S, Han A, et al. Haem-regulated eIF2alpha kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency. Br J Haematol. 2008; 143:129-137.
78. Lu L, Han AP, Chen JJ. Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses. Mol Cell Biol. 2001;21:7971-7980.
79. Scroggins BT, Prince T, Shao J, et al. High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients. Biochemistry. 2003;42:12550-12561.
80. Thulasiraman V, Yun BG, Uma S, Gu Y, Scroggins BT, Matts RL. Differential inhibition of Hsc70 activities by two Hsc70-binding peptides. Biochemistry. 2002;41:3742-3753.
81. Shao J, Grammatikakis N, Scroggins BT, et al. Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase. J Biol Chem. 2001;276:206-214.
82. Uma S, Thulasiraman V, Matts RL. Dual role for Hsc70 in the biogenesis and regulation of the heme-regulated kinase of the alpha subunit of eukaryotic translation initiation factor 2. Mol Cell Biol. 1999;19:5861-5871.
83. Thulasiraman V, Xu Z, Uma S, Gu Y, Chen JJ, Matts RL. Evidence that Hsc70 negatively modulates the activation of the heme-regulated eIF2alpha kinase in rabbit reticulocyte lysate. Eur J Biochem. 1998;255:552-562.
84. Xu Z, Pal JK, Thulasiraman V, Hahn HP, Chen JJ, Matts RL. The role of the 90-kDa heat-shock protein and its associated cohorts in stabilizing the heme-regulated eIF-2alpha kinase in reticulocyte lysates during heat stress. Eur J Biochem. 1997; 246:461-470.
85. Uma S, Hartson SD, Chen JJ, Matts RL. Hsp90 is obligatory for the heme-regulated eIF-2alpha kinase to acquire and maintain an activable conformation. J Biol Chem. 1997;272:11648-11656.
86. Forget BG, Pearson HA. Hemoglobin synthesis and the thalassemias. In: Handin RI, Lux SE, Stossel TP, eds. BLOOD Principles & Practice of Hematology. Philadelphia, PA: J. B. Lippincott Company; 1995:1525-1990.
87. Brunori M, Falcino G, Fioreti E. Formation of superoxide in the autoxidation of the isolated alpha and beta chains of human hemoglobin and its involvement in hemichrome precipitation. Eur Biochem. 1975;53:99-104.
88. Bunn HF, Forget BG. Hemoglobin Function. In: Bunn HF, Forget BG, eds. Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia, PA: W. B. Saunders; 1986:37-60.
89. Shaeffer JR. Evidence for soluble alpha-chains as intermediates in hemoglobin synthesis in the rabbit reticulocyte. Biochem Biophys Res Comm. 1967;28:647-652.
90. Tavill AS, Grayzel AI, Vanderhoff GA, London IM. The control of hemoglobin synthesis. Trans Assoc Am Physicians. 1967;80:305-313.
91. Olivieri NF, Weatherall DJ. Clinical aspects of beta thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin. Cambridge, United Kingdom: Cambridge University Press; 2001:277-341.
92. Shaeffer JR. Turnover of excess hemoglobin alpha chains in beta-thalassemic cells is ATP-dependent. J Biol Chem. 1983;258:13172-13177.
93. Shaeffer JR, Cohen RE. Enhancement by ubiquitin aldehyde of proteolysis of hemoglobin alpha subunits in beta-thalassemic hemolysates. Ann N Y Acad Sci. 1998;850:394-397.
94. Shaeffer JR, Kania MA. Degradation of monoubiquitinated alpha-globin by 26S proteasomes. Biochemistry. 1995;34:4015-4021.
95. Kaganovich D, Kopito R, Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature. 2008;454:1088-1095.
96. Vasseur-Godbillon C, Hamdane D, Marden MC, Baudin-Creuza V. High-yield expression in Escherichia coli of soluble human alpha-hemoglobin complexed with its molecular chaperone. Protein Eng Des Sel. 2006;19:91-97.
97. Kihm AJ, Kong Y, Hong W, et al. An abundant erythroid protein that stabilizes free alpha hemoglobin. Nature. 2002;417:758-763.
98. Kong Y, Zhou S, Kihm AJ, et al. Loss of alphahemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest. 2004;114:1457-1466.
99. Pinho FO, de Albuquerque DM, Olalla Saad ST, Costa FF. Reduction of AHSP synthesis in hemininduced K562 cells and EPO-induced CD34(+) cells leads to alpha-globin precipitation, impairment of normal hemoglobin production, and increased cell death. Exp Hematol. 2008;36:265-272.
100. Gell D, Kong Y, Eaton SA, Weiss MJ, Mackay JP. Biophysical characterization of the alpha-globin binding protein alpha-hemoglobin stabilizing protein. J Biol Chem. 2002;277:40602-40609.
101. Santiveri CM, Perez-Canadillas JM, Vadivelu MK, et al. NMR structure of the alpha-hemoglobin stabilizing protein: insights into conformational heterogeneity and binding. J Biol Chem. 2004;279: 34963-34970.
102. Feng L, Zhou S, Gu L, et al. Structure of oxidized alpha-haemoglobin bound to AHSP reveals a protective mechanism for haem. Nature. 2005;435: 697-701.
103. Feng L, Gell DA, Zhou S, et al. Molecular mechanism of AHSP-mediated stabilization of alphahemoglobin. Cell. 2004;119:629-640.
104. Baudin-Creuza V, Vasseur-Godbillon C, Pato C, Prehu C, Wajcman H, Marden MC. Transfer of human alpha-to beta-hemoglobin via its chaperone protein: evidence for a new state. J Biol Chem. 2004;279:36530-36533.
105. Zhou S, Olson JS, Fabian M, Weiss MJ, Gow AJ. Biochemical fates of alpha hemoglobin bound to alpha hemoglobin stabilizing protein (AHSP).J Biol Chem. 2006;281:32611-32618.
106. Yu X, Kong Y, Dore LC, et al. An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. J Clin Invest. 2007;117:1856-1865.
107. Dos Santos CO, Dore LC, Valentine E, et al. An iron responsive element-like stem-loop regulates alpha hemoglobin stabilizing protein mRNA. J Biol Chem. 2008;283:26956-26964.
108. Weiss MJ, Zhou S, Feng L, et al. Role of alpha hemoglobin-stabilizing protein in normal erythropoiesis and (3-thalassemia. Ann N YAcad Sci. 2005;1054:103-117.
109. Archer JE, Vega LR, Solomon F. Rbl2p, a yeast protein that binds to beta-tubulin and participates in microtubule function in vivo. Cell. 1995;82:425-434.
110. Cowan NJ, Lewis SA. Type II chaperonins, prefoldin, and the tubulin-specific chaperones. Adv Protein Chem. 2001;59:73-104.
111. Nagai N, Hosokawa M, Itohara S, et al. Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis. J Cell Biol. 2000;150:1499-1506.
112. Tasab M, Batten MR, Bulleid NJ. Hsp47: a molecular chaperone that interacts with and stabilizes correctly-folded procollagen. EMBO J. 2000; 19:2204-2211.
113. Giordano PC, Zweegman S, Akkermans N, et al. The first case of Hb Groene Hart [alpha119(H2)Pro→Ser, CCT→TCT (alpha1)] homozygosity confirms that a thalassemia phenotype is associated with this abnormal hemoglobin variant. Hemoglobin. 2007;31:179-182.
114. Lacerra G, Scarano C, Musollino G, Flagiello A, Pucci P, Carestia C. Hb Foggia or alpha 117 (GH5)Phe → Ser: a new alpha 2 globin allele affecting the alpha Hb-AHSP interaction. Haematologica. 2008;93:141-142.
115. Vasseur-Godbillon C, Marden MC, Giordano P, Wajcman H, Baudin-Creuza V. Impaired binding of AHSP to alpha chain variants: Hb Groene Hart illustrates a mechanism leading to unstable hemoglobins with alpha thalassemic like syndrome. Blood Cells Mol Dis. 2006;37:173-179.
116. dos Santos CO, Zhou S, Secolin R, et al. Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. Am J Hematol. 2008;83:103-108.
117. Viprakasit V, Tanphaichitr VS, Chinchang W, Sangkla P, Weiss MJ, Higgs DR. Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. Blood. 2004;103:3296-3299.
118. Glock B, Winter M, Rennhofer SO, et al. Transcript level of erythroid differentiation-related factor, a candidate surrogate marker for transmissible spongiform encephalopathy diseases in blood, shows a broad range of variation in healthy individuals. Transfusion. 2003;43:1706-1710.
119. Lai MI, Jiang J, Silver N, et al. Alpha-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. Br J Haematol. 2006;133:675-682.
120. Mai A, Jelicic K, Rotili D, et al. Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia. Mol Pharmacol. 2007;72:1111-1123.
121. Gallagher PG, Liem RI, Wong E, Weiss MJ, Bodine DM. GATA-1 and Oct-1 are required for expression of the human alpha-hemoglobin-stabilizing protein gene. J Biol Chem. 2005;280: 39016-39023.
122. Kanno H, Kamatani N, HamadaT, et al. Alpha hemoglobin stabilizing protein (AHSP) is a susceptibility gene to drug/infection-induced hemolytic anemia [abstract]. Blood. 2005;106:479a.
123. Emanuelli M, Sartini D, Rossi V, et al. Alpha-hemoglobin-stabilizing protein (AHSP) in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome, intrauterine growth restriction (IUGR) and fetal death. Cell Stress Chaperones. 2008; 13:67-71.
124. Galanello R, Perseu L, Giagu N, Sole G. AHSP expression in beta-thalassemia carriers with thalassemia intermedia phenotype [abstract]. Blood. 2003;102:1881.
125. dos Santos CO, Duarte AS, Saad ST, Costa FF. Expression of alpha hemoglobin stabilizing protein gene (AHSP) during erythropoiesis and beta thalassemia [abstract]. Blood. 2003;102:3837a.
126. dos Santos CO, Costa FF. AHSP and beta-thalassemia: a possible genetic modifier. Hematology. 2005;10:157-161.
127. Wefes I, Mastrandrea LD, Haldeman M, et al. Induction of ubiquitin-conjugating enzymes during terminal erythroid differentiation. Proc Natl Acad Sci U S A. 1995;92:4982-4986.
128. Dice JF. Chaperone-mediated autophagy. Autophagy. 2007;3:295-299.
129. Zhang J, Ney PA. NIX induces mitochondrial autophagy in reticulocytes. Autophagy. 2008;4:354-356.
130. Schweers RL, Zhang J, Randall MS, et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci U S A. 2007;104:19500-19505.
131. Sandoval H, Thiagarajan P, Dasgupta SK, et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature. 2008;454:232-235.
132. Yamanaka K, Ishikawa H, Megumi Y, et al. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat Cell Biol. 2003;5:336-340.
133. Ishikawa H, Kato M, Hori H, et al. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol Cell. 2005; 19:171-181.
134. Zumbrennen KB, Hanson ES, Leibold EA. HOIL-1 is not required for iron-mediated IRP2 degradation in HEK293 cells. Biochim Biophys Acta. 2008;1783:246-252.
135. Morimoto RI. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 2008;22:1427-1438.
136. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319:916-919.
137. Rangaraju S, Madorsky I, Pileggi JG, Kamal A, Notterpek L. Pharmacological induction of the heat shock response improves myelination in a neuropathic model. Neurobiol Dis. 2008;32:105-115.
138. KitamuraA, Kubota H, Pack CG, et al. Cytosolic chaperonin prevents polyglutamine toxicitywith altering the aggregation state. Nat Cell Biol. 2006;8:1163-1170.
139. Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, Burnstock G, Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med. 2004;10:402-405.
140. Fujikake N, Nagai Y, Popiel HA, Okamoto Y, Yamaguchi M, Toda T. Heat shock transcription factor 1 (HSF1)-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J Biol Chem. 2008;283:26188-26197.
141. Dickey CA, Kamal A, Lundgren K, et al. The high affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest. 2007;117:648-658.
142. Cummings CJ, Sun Y, Opal P, et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet. 2001;10:1511-1518.
143. Cummings CJ, Mancini MA, AntalffyB, DeFranco DB, Orr HT, Zoghbi HY. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998;19:148-154.
144. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM. Chaperone suppression of alpha synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 2002;295:865-868.
145. Adachi H, Waza M, Tokui K, et al. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J Neurosci. 2007;27:5115-5126.
146. Lo Bianco C, Shorter J, Regulier E, et al. Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J Clin Invest. 2008; 118:3087-3097.